Revenue
YoY −7.0%$8.2B TTM$1.9B Q3 '26
FY22FY23FY24FY25TTM
Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
SOLV
$90.38+3.67%
as of close, Nov 6, 2026
☾ AH $90.38 +3.67%
Solventum CorporationStock · HealthcareS&P 500 Equal Weight · 0.2% of RSPS&P 500 · 0.02% of SPYRussell 1000 · 0.02% of IWBRussell 3000 · 0.02% of IWVUS Stock Market · 0.02% of VTI
Head-to-head:Compare with BAX or any ticker →
SOLV financial statements
The full income statement, balance sheet, and cash-flow statement for Solventum Corporation (SOLV), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Financial overview#
Gross profit
YoY −6.4%$4.5B TTM$1.1B Q3 '26
FY22FY23FY24FY25TTM
Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Operating income
YoY −96.0%$454M TTM$68M Q3 '26
FY22FY23FY24FY25TTM
Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Net income
YoY n/m$156M TTM−$12M Q3 '26
FY22FY23FY24FY25TTM
Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
EPS (diluted)
YoY n/m$0.90 TTM−$0.07 Q3 '26
FY22FY23FY24FY25TTM
Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Operating cash flow
YoY +132.9%$310M TTM$177M Q3 '26
FY22FY23FY24FY25TTM
Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Capital expenditure
YoY −17.5%$310M TTM$80M Q3 '26
FY22FY23FY24FY25TTM
Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Free cash flow
YoY n/m$0 TTM$97M Q3 '26
FY22FY23FY24FY25TTM
Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares (diluted)
YoY −2.6%173.9M TTM170.8M Q3 '26
FY22FY23FY24FY25TTM
Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares outstanding (point-in-time)
2024-09 172.8M2024-12 173.0M2025-03 173.0M2025-06 173.4M2025-09 173.4M2025-12 173.5M2026-03 173.2M2026-06 170.2M2026-09 169.7M-1.7% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
PeriodRangeOrderChangeFiguresAs-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | |
| 8.32B+0.9% | 8.25B+0.7% | 8.20B+0.8% | 8.13B | ||
| Lease income | 615M+2.5% | 600M-2.6% | 616M+2.2% | 603M | |
| 4.45B-3.1% | 4.59B-2.1% | 4.69B-0.0% | 4.70B | ||
| Cost of revenue | 3.87B+5.8% | 3.66B+4.5% | 3.50B+2.0% | 3.44B | |
| Research & development | 739M-4.6% | 775M+2.2% | 758M-1.2% | 767M | |
| Selling, general & administrative | 3.08B+10.7% | 2.78B+21.0% | 2.30B+2.9% | 2.23B | |
| Restructuring | — | 62.0M | — | — | |
| Amortization of intangibles | 312M-10.6% | 349M-4.4% | 365M-2.1% | 373M | |
| Operating income | 2.18B+110.5% | 1.04B-38.8% | 1.69B-0.1% | 1.69B | |
| Other non-operating income | -39.0M+39.1% | -64.0M-156.0% | -25.0M-2400.0% | -1.00M | |
| Pre-tax income | 1.71B+183.1% | 605M-63.7% | 1.67B-1.5% | 1.69B | |
| Income tax | 157M+23.6% | 127M-60.4% | 321M-8.0% | 349M | |
| 1.56B+224.8% | 479M-64.4% | 1.35B+0.2% | 1.34B | ||
| Net income to common | 1.56B+224.8% | 479M-64.4% | 1.35B+0.2% | 1.34B | |
| $8.88+221.7% | $2.76-64.6% | $7.79+0.1% | $7.78 | ||
| EPS (basic) | $8.94+222.7% | $2.77-64.4% | $7.79+0.1% | $7.78 | |
| Weighted-avg shares (basic) | 174M+0.5% | 173M+0.3% | 173M+0.0% | 173M | |
| Weighted-avg shares (diluted) | 175M+0.9% | 174M+0.6% | 173M+0.0% | 173M | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | |
| 3.86B+18.8% | 3.25B+29.0% | 2.52B+12.9% | 2.23B | ||
| Cash & equivalents | 878M+15.2% | 762M+292.8% | 194M+218.0% | 61.0M | |
| Accounts receivable | 1.03B-1.0% | 1.04B-20.5% | 1.31B+12.1% | 1.17B | |
| Inventory | 1.07B+10.5% | 965M+12.6% | 857M-1.8% | 873M | |
| Other current assets | 731M+149.5% | 293M+89.0% | 155M+23.0% | 126M | |
| 14.3B-1.1% | 14.5B+3.7% | 13.9B+2.6% | 13.6B | ||
| Property, plant & equipment | 1.33B-18.2% | 1.62B+11.3% | 1.46B+10.5% | 1.32B | |
| Operating lease right-of-use | 214M+21.6% | 176M+79.6% | 98.0M | — | |
| Goodwill | 5.70B-10.6% | 6.38B-2.4% | 6.54B+1.6% | 6.43B | |
| Intangible assets | 2.59B+1.9% | 2.54B-12.3% | 2.90B-10.8% | 3.25B | |
| Deferred tax assets | 263M | — | — | — | |
| Other non-current assets | 814M+22.4% | 665M+25.5% | 530M+48.0% | 358M | |
| 3.14B+16.0% | 2.70B+56.4% | 1.73B+31.8% | 1.31B | ||
| Accounts payable | 687M+11.2% | 618M+29.6% | 477M+37.1% | 348M | |
| Accrued liabilities | 435M+59.9% | 272M | 0.00 | — | |
| Deferred revenue | 621M+8.6% | 572M-0.3% | 574M+2.7% | 559M | |
| Short-term & current debt | 0.00-100.0% | 200M | 0.00 | — | |
| Current lease liability | 70.0M-19.5% | 87.0M+200.0% | 29.0M | — | |
| Other current liabilities | 1.39B+33.8% | 1.04B+53.8% | 677M+67.6% | 404M | |
| 9.24B-19.6% | 11.5B+405.0% | 2.28B+22.9% | 1.85B | ||
| Long-term debt | 5.04B-35.5% | 7.81B | 0.00 | — | |
| Non-current lease liability | 142M+65.1% | 86.0M+24.6% | 69.0M | — | |
| Operating lease liability (total) | 212M+22.5% | 173M+76.5% | 98.0M | — | |
| Finance lease liability | 0.00 | — | — | — | |
| Deferred tax liabilities | 164M-27.1% | 225M-2.6% | 231M+7.4% | 215M | |
| Other non-current liabilities | 547M+33.4% | 410M+169.7% | 152M-35.3% | 235M | |
| 5.05B+70.6% | 2.96B-74.6% | 11.7B-0.6% | 11.7B | ||
| Common stock | 2.00M+0.0% | 2.00M | 0.00 | — | |
| Additional paid-in capital | 3.88B+2.8% | 3.77B | 0.00 | — | |
| Retained earnings | 1.80B+642.6% | 242M | 0.00 | — | |
| Treasury stock | 0.00 | — | — | — | |
| Accumulated other comprehensive income | -625M+40.8% | -1.06B-213.4% | -337M+32.2% | -497M | |
| Total equity incl. non-controlling | 5.05B+70.6% | 2.96B-74.6% | 11.7B-0.6% | 11.7B | |
| Total liabilities & equity | 14.3B-1.1% | 14.5B+3.7% | 13.9B+2.6% | 13.6B | |
| Common shares issued | 173M+0.4% | 173M | — | — | |
| Common shares outstanding | 173M+0.4% | 173M | — | — | |
| Shares outstanding (cover) | 173M+0.3% | 173M | — | — | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | |
| 369M-68.9% | 1.19B-38.1% | 1.92B+14.1% | 1.68B | ||
| Depreciation & amortization | 489M-11.9% | 555M-1.1% | 561M-2.9% | 578M | |
| Intangible amortization | 312M-10.6% | 349M-4.4% | 365M-2.1% | 373M | |
| Share-based compensation | 161M+43.8% | 112M+187.2% | 39.0M+5.4% | 37.0M | |
| Deferred income taxes | -120M+22.6% | -155M-9.2% | -142M-0.7% | -141M | |
| Change in receivables | -34.0M+20.9% | -43.0M-133.3% | 129M+303.1% | 32.0M | |
| Change in inventory | 139M+5.3% | 132M+673.9% | -23.0M-128.0% | 82.0M | |
| Change in payables | 104M-60.9% | 266M+153.3% | 105M+320.0% | 25.0M | |
| Other operating activities | -194M-389.6% | 67.0M+546.7% | -15.0M+86.7% | -113M | |
| 2.80B+836.1% | -380M-65.2% | -230M+9.1% | -253M | ||
| Capital expenditure | 379M-0.3% | 380M+31.0% | 290M+15.5% | 251M | |
| Free cash flow | -10.0M-101.2% | 805M-50.5% | 1.63B+13.8% | 1.43B | |
| Acquisitions | 696M | 0.00 | 0.00 | 0.00 | |
| Other investing activities | 18.0M | 0.00 | 0.00-100.0% | 2.00M | |
| -3.06B-1173.8% | -240M+84.5% | -1.55B-6.3% | -1.46B | ||
| Long-term debt issued | 0.00-100.0% | 8.30B | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other financing activities | 46.0M+475.0% | 8.00M+700.0% | 1.00M+125.0% | -4.00M | |
| Net change in cash | 116M-79.6% | 568M+327.1% | 133M+543.3% | -30.0M | |
| Interest paid | 442M+54.0% | 287M | 0.00 | 0.00 | |
| Income taxes paid | 181M-25.8% | 244M | 0.00 | 0.00 | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | |
| Market cap | 13.7B+20.4% | 11.4B | — | — | |
| P/E | 8.8×-62.9% | 23.8× | — | — | |
| P/S | 1.7×+19.4% | 1.4× | — | — | |
| P/B | 2.7×-29.4% | 3.9× | — | — | |
| P/FCF | — | 14.2× | — | — | |
| Earnings yield | 11.3%+169.7% | 4.2% | — | — | |
| FCF yield | — | 7.1% | — | — | |
| Source filing | 10-K | 10-K | 10-K | 10-K |
CEO pay#
As charts →| Fiscal year | CEO | Total, as reported | Actually paid | Other executives, average | $100 in the stock | $100 in peers |
|---|---|---|---|---|---|---|
| FY2025 | Bryan C. Hanson | $20.1M | $40M | $5.1M | $114.67 | $108.95 |
| FY2024 | — | $40M | $40.2M | $8.5M | $95.60 | $95.07 |
From the pay-versus-performance table of each proxy statement (DEF 14A), the newest that states the year. “Actually paid” values stock awards at the year’s closing price, so it falls when the stock does. A year two chief executives shared lists each one’s pay, as reported / actually paid, and the totals are both. $100 in the stock and in the peer group the proxy names are the newest proxy’s, from the start of its first year.
About this data
Source: SOLV’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all SOLV filings on SEC EDGAR → Not investment advice.
Head-to-head:Compare with BAX or any ticker →